scispace - formally typeset
A

Almudena Castro Conde

Researcher at Hospital Universitario La Paz

Publications -  19
Citations -  1584

Almudena Castro Conde is an academic researcher from Hospital Universitario La Paz. The author has contributed to research in topics: Myocardial infarction & Diabetes mellitus. The author has an hindex of 6, co-authored 16 publications receiving 1208 citations.

Papers
More filters
Journal ArticleDOI

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries:

TL;DR: A large majority of coronary patients do not achieve the guideline standards for secondary prevention with high prevalences of persistent smoking, unhealthy diets, physical inactivity and consequently most patients are overweight or obese with a high prevalence of diabetes.
Journal ArticleDOI

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.

Kornelia Kotseva, +71 more
TL;DR: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors, and a majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets.
Journal ArticleDOI

Lifestyle and risk factor management in people at high risk of cardiovascular disease : a report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

TL;DR: The European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV in primary care was a cross-sectional survey carried out by the European Society of Cardiology, EURObservational Research Programme in 2014-2015 in 71 centres from 14 European countries as mentioned in this paper.
Journal ArticleDOI

Necesidades no cubiertas con el tratamiento hipolipemiante oral: documento de posición de la Sociedad Española de Cardiología

TL;DR: Here, PCSK9 inhibitors have demonstrated safety and efficacy in the treatment of dyslipidemia, and these drugs have recently been approved for clinical use by Spanish regulatory agencies, with the aim of reducing cardiovascular risk in selected patient groups.
Journal ArticleDOI

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.

TL;DR: In patients with stabilized CHD, comorbid conditions that may reflect the ubiquitous nature of atherosclerosis, dominate lifestyle-related and other modifiable risk factors in terms of prognosis, at least over a 2-year follow-up period.